Severe Depression
Body clocks of depressed people altered at cell level, researchers show
Every cell in our bodies runs on a 24-hour clock, tuned to the night-day, light-dark cycles that have ruled us since the dawn of humanity. The brain acts as timekeeper, keeping the cellular clock in sync ...
Medical research
May 13, 2013 |
4 / 5 (19) |
4
|
The Lancet Series on bipolar disorder
Bipolar disorder – where patients experience recurrent episodes of mood disturbance, ranging from extreme elation (mania) to severe depression – is thought to affect roughly 2% of the world's population in its most pronounced ...
Psychology & Psychiatry
May 09, 2013 |
not rated yet |
0
Nerve stimulation for severe depression changes brain function
For nearly a decade, doctors have used an implanted electronic stimulator to treat severe depression in people who don't respond to standard antidepressant therapy.
Psychology & Psychiatry
May 07, 2013 |
not rated yet |
0
|
Exercise proves to be ineffective against care home depression
Researchers at the University of Warwick and Queen Mary, University of London have shown that exercise is not effective in reducing burden of depression among elderly care home residents.
Health
May 02, 2013 |
5 / 5 (1) |
0
Antidepressants may hasten bypass recovery, study finds
(HealthDay)—Depression is relatively common in patients who undergo heart bypass surgery, and a new study finds that short-term use of antidepressants may aid patients' recovery.
Surgery
May 01, 2013 |
not rated yet |
0
Researchers look at therapeutic benefits of ketamine
The largest trial into the use of Electroconvulsive Therapy (ECT) in the UK in more than 30 years will look into how the use of the Class C drug ketamine might reduce the side effects of ECT for those being treated for severe ...
Psychology & Psychiatry
May 01, 2013 |
not rated yet |
0
ECT can restore quality of life for some severely depressed patients
Patients whose severe depression goes into remission for six months following electroconvulsive therapy report a quality of life similar to that of healthy individuals, researchers say.
Psychology & Psychiatry
Apr 15, 2013 |
not rated yet |
0
|
Study finds mothers with postpartum depression want online professional treatment
Mothers suffering from postpartum depression after a high-risk pregnancy would turn to online interventions if available anonymously and from professional healthcare providers, according to researchers from Case Western Reserve ...
Psychology & Psychiatry
Apr 04, 2013 |
not rated yet |
0
Targeting mental defeat among pain patients could prevent anxiety and depression
(Medical Xpress)—A new study of Hong Kong chronic pain patients suggests that targeting feelings of mental defeat could prevent severe depression, anxiety and interference with daily activities.
Health
Apr 03, 2013 |
not rated yet |
0
Researchers studying ketamine as suicide prevention drug
(Medical Xpress)—University of Alabama at Birmingham (UAB) researchers think ketamine, an anesthesia medication in use since the 1970s, might be a valuable tool in treating severe depression and reducing ...
Psychology & Psychiatry
Mar 27, 2013 |
5 / 5 (1) |
0
Heart failure patients with depression have four times risk of death
Heart failure patients who are moderately or severely depressed have four times the risk of dying and double the risk of having to go to the emergency room or be hospitalized compared to those who are not depressed, according ...
Cardiology
Mar 19, 2013 |
not rated yet |
0
Self help books and websites can benefit severely depressed patients
Patients with more severe depression show at least as good clinical benefit from 'low-intensity' interventions, such as self help books and websites, as less severely ill patients, suggests a paper published on BMJ websit ...
Psychology & Psychiatry
Feb 26, 2013 |
not rated yet |
0
Study finds no tie between acne drug accutane and Crohn's, colitis
(HealthDay)—A new study counters the notion that the prescription acne drug Accutane raises the risk of Crohn's disease or colitis in women.
Diseases, Conditions, Syndromes
Feb 20, 2013 |
not rated yet |
0
Could an old antidepressant treat sickle cell disease?
(Medical Xpress)—An antidepressant drug used since the 1960s may also hold promise for treating sickle cell disease, according to a surprising new finding made in mice and human red blood cells by a team ...
Medical research
Feb 19, 2013 |
5 / 5 (4) |
0
|
Are antidepressants overprescribed?
Antidepressant prescriptions in the UK have increased by 9.6% in 2011, to 46 million prescriptions. Does this reflect overmedicalisation or appropriate treatment? Two experts debate the issue on BMJ website today.
Psychology & Psychiatry
Jan 22, 2013 |
not rated yet |
0
Major depressive disorder (MDD) (also known as recurrent depressive disorder, clinical depression, major depression, unipolar depression, or unipolar disorder) is a mental disorder characterized by an all-encompassing low mood accompanied by low self-esteem, and by loss of interest or pleasure in normally enjoyable activities. This cluster of symptoms (syndrome) was named, described and classified as one of the mood disorders in the 1980 edition of the American Psychiatric Association's diagnostic manual. The term "depression" is ambiguous. It is often used to denote this syndrome but may refer to other mood disorders or to lower mood states lacking clinical significance. Major depressive disorder is a disabling condition that adversely affects a person's family, work or school life, sleeping and eating habits, and general health. In the United States, around 3.4% of people with major depression commit suicide, and up to 60% of people who commit suicide had depression or another mood disorder.
The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a mental status examination. There is no laboratory test for major depression, although physicians generally request tests for physical conditions that may cause similar symptoms. If depressive disorder is not detected in the early stages it may result in a slow recovery and affect or worsen the person's physical health. Standardized screening tools such as Major Depression Inventory can be used to detect major depressive disorder. The most common time of onset is between the ages of 20 and 30 years, with a later peak between 30 and 40 years.
Typically, patients are treated with antidepressant medication and, in many cases, also receive psychotherapy or counseling, although the effectiveness of medication for mild or moderate cases is questionable. Hospitalization may be necessary in cases with associated self-neglect or a significant risk of harm to self or others. A minority are treated with electroconvulsive therapy (ECT). The course of the disorder varies widely, from one episode lasting weeks to a lifelong disorder with recurrent major depressive episodes. Depressed individuals have shorter life expectancies than those without depression, in part because of greater susceptibility to medical illnesses and suicide. It is unclear whether or not medications affect the risk of suicide. Current and former patients may be stigmatized.
The understanding of the nature and causes of depression has evolved over the centuries, though this understanding is incomplete and has left many aspects of depression as the subject of discussion and research. Proposed causes include psychological, psycho-social, hereditary, evolutionary and biological factors. Certain types of long-term drug use can both cause and worsen depressive symptoms. Psychological treatments are based on theories of personality, interpersonal communication, and learning. Most biological theories focus on the monoamine chemicals serotonin, norepinephrine and dopamine, which are naturally present in the brain and assist communication between nerve cells.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.
Latest Spotlight News
Researchers find possible 'master switch' in deadly brain cancer
(Medical Xpress)—Researchers at the University of Virginia School of Medicine have identified a promising target for treating glioblastoma, one that appears to avoid many of the obstacles that typically frustrate efforts ...
Depression linked to telomere enzyme, aging, chronic disease
(Medical Xpress)—The first symptoms of major depression may be behavioral, but the common mental illness is based in biology—and not limited to the brain.
Vaccine blackjack: IL-21 critical to fight against viral infections
(Medical Xpress)—Scientists at Emory Vaccine Center have shown that an immune regulatory molecule called IL-21 is needed for long-lasting antibody responses in mice against viral infections.
Slowing the aging process—only with antibiotics
Swiss scientists reveal the mechanism responsible for aging hidden deep within mitochondria—and dramatically slow it down in worms by administering antibiotics to the young.
Researchers complete largest genetic sequencing study of human disease
Researchers from Queen Mary, University of London have led the largest sequencing study of human disease to date, investigating the genetic basis of six autoimmune diseases.
Brain can be trained in compassion, study shows
Until now, little was scientifically known about the human potential to cultivate compassion—the emotional state of caring for people who are suffering in a way that motivates altruistic behavior.
Having both migraines, depression may mean smaller brain
(HealthDay)—Migraines and depression can each cause a great deal of suffering, but new research indicates the combination of the two may be linked to something else entirely—a smaller brain.
Novel approach for influenza vaccination shows promise in early animal testing
A new approach for immunizing against influenza elicited a more potent immune response and broader protection than the currently licensed seasonal influenza vaccines when tested in mice and ferrets. The vaccine ...
Enzyme-activating antibodies revealed as marker for most severe form of rheumatoid arthritis
In a series of lab experiments designed to unravel the workings of a key enzyme widely considered a possible trigger of rheumatoid arthritis, researchers at Johns Hopkins have found that in the most severe ...
Research offers promising new approach to treatment of lung cancer
Researchers have developed a new drug delivery system that allows inhalation of chemotherapeutic drugs to help treat lung cancer, and in laboratory and animal tests it appears to reduce the systemic damage ...